The use of mice deficient in MCT8 to identify a mechanism regulating thyroid hormone secretion

The mechanism of thyroid hormone (TH) secretion from the thyroid gland into the bloodstream is still unknown. The aim of my thesis has been to investigate the role of monocarboxylate transporter 8 (MCT8) in this process. To accomplish the goal, we used the Mct8 deficient mice (Mct8KO), generated by homologous recombination. MCT8 is a specific transporter of TH across the cell membrane, active in both uptake and efflux. Mutations of MCT8 gene cause in human severe psychomotor retardation and thyroid function test abnormalities. The Mct8KO mice faithfully replicate the endocrine aberrances observed in humans, including a low concentration of serum thyroxine (T4). This latter finding cannot be fully explained by increased deiodination. Here, we have shown that Mct8 is localized at the basolateral membrane of thyrocytes and that the serum TH concentration is reduced in Mct8KO mice early after being taken off a treatment that almost completely depleted the thyroid gland of TH. Furthermore, thyroid glands in Mct8KO mice contained 2.3-fold and 1.5-fold more non thyroglobulin associated T4 and triiodothyronine (T3), respectively, than did those in wild-type (Wt) mice. This was independent of deiodination, as comparable increases were also found in Mct8KO mice which lacked the types 1 and 2 deiodinases. In addition, depletion of thyroidal TH content was slower during iodine deficiency. After administration of 125I, the rate of both its secretion from the thyroid gland and its appearance in the serum as trichloroacetic acid-precipitable radioactivity were greatly reduced in Mct8KO mice. Similarly, the secretion of T4 induced by injection of thyrotropin was reduced in Mct8KO in which endogenous TSH and T4 were suppressed by administration of T3. This study is the first to demonstrate that Mct8 is involved in the secretion of TH from the thyroid gland. The defect in the efflux contributes, in part, to the low serum T4 level observed in Mct8 deficiency

Identification and Functional Studies of Two New Dual-Oxidase 2 (DUOX2) Mutations in a Child with Congenital Hypothyroidism and a Eutopic Normal-Size Thyroid Gland

n/

A Roadmap for HEP Software and Computing R&D for the 2020s

Particle physics has an ambitious and broad experimental programme for the coming decades. This programme requires large investments in detector hardware, either to build new facilities and experiments, or to upgrade existing ones. Similarly, it requires commensurate investment in the R&D of software to acquire, manage, process, and analyse the shear amounts of data to be recorded. In planning for the HL-LHC in particular, it is critical that all of the collaborating stakeholders agree on the software goals and priorities, and that the efforts complement each other. In this spirit, this white paper describes the R&D activities required to prepare for this software upgrade.Peer reviewe

Iodine deficiency from pregnancy to childhood

Iodine is a micronutrient essential for mammalian life because it is critical for the synthesis of thyroid hormones, thyroxine (T4), and triiodothyronine (T3), which contain in their molecules four and three atoms of iodine, respectively. Thyroid hormones (TH) are important for the growth and development of different tissues, especially the central nervous system and the skeleton, for the cardiac and gastrointestinal function, and for the regulation of the energy homeostasis throughout life. Disturbances in TH availability during early embryonic development, as in maternal iodine deficiency, cause severe neurological abnormalities in the newborns [1]. The World Health Organization (WHO) considers iodine deficiency to be “the single most important preventable cause of brain damage” worldwide [2]. Despite the great improvements in global iodine nutrition in the last century, it is currently estimated that iodine deficiency still affects 241 million school-aged children [3]

Clinical Study A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women

Introduction. We evaluated the effects of a therapy that combines myo-inositol (MI) and D-chiro-inositol (DCI) in young overweight women affected by polycystic ovary syndrome (PCOS), characterized by oligo-or anovulation and hyperandrogenism, correlated to insulin resistance. Methods. We enrolled 46 patients affected by PCOS and, randomly, we assigned them to two groups, A and B, treated, respectively, with the association of MI plus DCI, in a 40 : 1 ratio, or with placebo (folic acid) for six months. Thus, we analyzed pretreatment and posttreatment FSH, LH, 17-beta-Estradiol, Sex Hormone Binding Globulin, androstenedione, free testosterone, dehydroepiandrosterone sulphate, HOMA index, and fasting glucose and insulin. Results. We recorded a statistically significant reduction of LH, free testosterone, fasting insulin, and HOMA index only in the group treated with the combined therapy of MI plus DCI; in the same patients, we observed a statistically significant increase of 17-beta-Estradiol levels. Conclusions. The combined therapy of MI plus DCI is effective in improving endocrine and metabolic parameters in young obese PCOS affected women

A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women

Introduction. We evaluated the effects of a therapy that combines myo-inositol (MI) and D-chiro-inositol (DCI) in young overweight women affected by polycystic ovary syndrome (PCOS), characterized by oligo- or anovulation and hyperandrogenism, correlated to insulin resistance. Methods. We enrolled 46 patients affected by PCOS and, randomly, we assigned them to two groups, A and B, treated, respectively, with the association of MI plus DCI, in a 40 : 1 ratio, or with placebo (folic acid) for six months. Thus, we analyzed pretreatment and posttreatment FSH, LH, 17-beta-Estradiol, Sex Hormone Binding Globulin, androstenedione, free testosterone, dehydroepiandrosterone sulphate, HOMA index, and fasting glucose and insulin. Results. We recorded a statistically significant reduction of LH, free testosterone, fasting insulin, and HOMA index only in the group treated with the combined therapy of MI plus DCI; in the same patients, we observed a statistically significant increase of 17-beta-Estradiol levels. Conclusions. The combined therapy of MI plus DCI is effective in improving endocrine and metabolic parameters in young obese PCOS affected women

A Not So Benign Family Pedigree With Hereditary Chorea: A Broader Phenotypic Expression or Additional Picture?

NKX2-1 mutations have been usually associated with a non-progressive neurological disease. Recent reports revealed a vast variability regarding its clinical expressivity. Aim of this work was widening the Benign Hereditary Chorea neurological, cognitive and behavioral phenotype through the description of a child and her family pedigree. Molecular analysis focused on NKX2-1 gene revealed a novel frameshift mutation in the three-generation members described. Cognitive scales detected a relevant developmental delay, and the clinical observation and Autism Diagnostic Observation Schedule -2 administration allowed the diagnosis of autism spectrum disorder in the proband. Microarray testing, further executed to exclude a double hit contextually provoking the complex neurodevelopmental disorder, revealed the 22q11.2 Duplication Syndrome. This paper may contribute to enlarge Benign Hereditary Chorea variable expressivity and, together with other studies reported in the literature, underlines the need to reconsider the term "benign," verifying the opportunity of more a complex diagnosis

Disruption of the melanin-concentrating hormone receptor 1 (MCH1R) affects thyroid function

Melanin-concentrating hormone (MCH) is a peptide produced in the hypothalamus and the zona incerta that acts on one receptor, MCH receptor 1 (MCH1R), in rodents. The MCH system has been implicated in the regulation of several centrally directed physiological responses, including the hypothalamus-pituitary-thyroid axis. Yet a possible direct effect of the MCH system on thyroid function has not been explored in detail. We now show that MCH1R mRNA is expressed in thyroid follicular cells and that mice lacking MCH1R [MCH1R-knockout (KO)] exhibit reduced circulating iodothyronine (T4, free T4, T3, and rT3) levels and high TRH and TSH when compared with wild-type (WT) mice. Because the TSH of MCH1R-KO mice displays a normal bioactivity, we hypothesize that their hypothyroidism may be caused by defective thyroid function. Yet expression levels of the genes important for thyroid hormones synthesis or secretion are not different between the MCH1R-KO and WT mice. However, the average thyroid follicle size of the MCH1R-KO mice is larger than that of WT mice and contained more free and total T4 and T3 than the WT glands, suggesting that they are sequestered in the glands. Indeed, when challenged with TSH, the thyroids of MCH1R-KO mice secrete lower amounts of T4. Similarly, secretion of iodothyronines in the plasma upon 125I administration is significantly reduced in MCH1R-KO mice. Therefore, the absence of MCH1R affects thyroid function by disrupting thyroid hormone secretion. To our knowledge, this study is the first to link the activity of the MCH system to the thyroid function. Copyright © 2012 by The Endocrine Society.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Papillary thyroid cancer in a patient with congenital goitrous hypothyroidism due to a novel deletion in NIS gene

Iodide transport defect (ITD) is a rare cause of congenital hypothyroidism (CH) caused by sodium/iodide symporter (NIS) gene mutations. We report a novel NIS gene deletion in a patient with congenital hypothyroidism, goiter and papillary thyroid cancer . The proband was a 40 years old woman affected by CH treated unevenly with levothyroxine (L-T4) since the first year of age. She presented with a recurrence of multinodular goiter containing two indeterminate nodules and lack of iodide uptake by thyroid, salivary glands and stomach one month after L-T4 withdrawal. A second thyroidectomy was performed and one nodule was a papillary thyroid carcinoma (PTC) at histology. One proband’s brother was also affected by CH and developed a large multinodular goiter. After extracting genomic DNA from peripheral white blood cells and total RNA from thyroid tissue, all 15 exons of NIS gene were amplified and sequenced. No amplification band was obtained from the genomic DNA of the patient from exons 8 to 12 suggesting a large deletion. Direct sequencing of cDNA revealed a homozygous deletion producing a protein lacking of 185 amino acids. The same defect was present in the affected brother. We describe the first case of a patient with papillary thyroid carcinoma associated with dyshormonogenetic goiter due to a deletion of the NIS protein. The lack of a functioning NIS raises the question of how to complete the treatment of infiltrative PTC in this patient

Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion

The mechanism of thyroid hormone (TH) secretion from the thyroid gland into blood is unknown. Humans and mice deficient in monocarboxylate transporter 8 (MCT8) have low serum thyroxine (T4) levels that cannot be fully explained by increased deiodination. Here, we have shown that Mct8 is localized at the basolateral membrane of thyrocytes and that the serum TH concentration is reduced in Mct8-KO mice early after being taken off a treatment that almost completely depleted the thyroid gland of TH. Thyroid glands in Mct8-KO mice contained more non-thyroglobulin-associated T4 and triiodothyronine than did those in wild-type mice, independent of deiodination. In addition, depletion of thyroidal TH content was slower during iodine deficiency. After administration of 125I, the rate of both its secretion from the thyroid gland and its appearance in the serum as trichloroacetic acid–precipitable radioactivity was greatly reduced in Mct8-KO mice. Similarly, the secretion of T4 induced by injection of thyrotropin was reduced in Mct8-KO in which endogenous TSH and T4 were suppressed by administration of triiodothyronine. To our knowledge, this study is the first to demonstrate that Mct8 is involved in the secretion of TH from the thyroid gland and contributes, in part, to the low serum T4 level observed in MCT8-deficient patients